Wáng, Yi Xiang J. https://orcid.org/0000-0001-5697-0717
Blake, Glen M.
Xiao, Ben-Heng
Guglielmi, Giuseppe
Su, Yi
Jiang, Yebin
Guermazi, Ali
Kwok, Timothy C. Y.
Griffith, James F.
Article History
Received: 19 June 2023
Revised: 2 August 2023
Accepted: 2 August 2023
First Online: 11 August 2023
Declarations
:
: Ali Guermazi is a Shareholder of BICL, LLC and Consultant to Pfizer, ICM, TrialSpark, TissueGene, Coval, Medipost, and Novartis. Other authors declare no competing interests.